EMVision Medical Devices Past Earnings Performance
Past criteria checks 0/6
EMVision Medical Devices has been growing earnings at an average annual rate of 0.7%, while the Medical Equipment industry saw earnings growing at 8.3% annually. Revenues have been growing at an average rate of 42.7% per year.
Key information
0.7%
Earnings growth rate
7.2%
EPS growth rate
| Medical Equipment Industry Growth | 5.8% |
| Revenue growth rate | 42.7% |
| Return on equity | -14.7% |
| Net Margin | -23.6% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
EMVision Medical Devices (ASX:EMV) Is Using Debt Safely
Aug 28
Is EMVision Medical Devices (ASX:EMV) A Risky Investment?
Nov 21Here's Why We're Not At All Concerned With EMVision Medical Devices' (ASX:EMV) Cash Burn Situation
Apr 24EMVision Medical Devices Ltd's (ASX:EMV) CEO Compensation Is Looking A Bit Stretched At The Moment
Nov 09We're Not Very Worried About EMVision Medical Devices' (ASX:EMV) Cash Burn Rate
Oct 04Companies Like EMvision Medical Devices (ASX:EMV) Are In A Position To Invest In Growth
Jun 17We're Not Very Worried About EMvision Medical Devices' (ASX:EMV) Cash Burn Rate
Jan 07We're Not Very Worried About EMvision Medical Devices' (ASX:EMV) Cash Burn Rate
Oct 04We're Not Very Worried About EMvision Medical Devices' (ASX:EMV) Cash Burn Rate
Jun 08Here's Why We're Not Too Worried About EMvision Medical Devices' (ASX:EMV) Cash Burn Situation
Feb 22Investors Who Bought EMvision Medical Devices (ASX:EMV) Shares A Year Ago Are Now Up 319%
Dec 20
We Think EMvision Medical Devices (ASX:EMV) Can Afford To Drive Business Growth
Nov 24Revenue & Expenses Breakdown
How EMVision Medical Devices makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 12 | -3 | 8 | 5 |
| 31 Mar 24 | 10 | -3 | 8 | 4 |
| 31 Dec 23 | 9 | -3 | 8 | 3 |
| 30 Sep 23 | 8 | -4 | 8 | 3 |
| 30 Jun 23 | 7 | -4 | 8 | 2 |
| 31 Mar 23 | 6 | -4 | 8 | 2 |
| 31 Dec 22 | 6 | -5 | 8 | 2 |
| 30 Sep 22 | 5 | -5 | 8 | 2 |
| 30 Jun 22 | 4 | -6 | 8 | 2 |
| 31 Mar 22 | 4 | -7 | 8 | 2 |
| 31 Dec 21 | 3 | -7 | 8 | 2 |
| 30 Sep 21 | 3 | -8 | 8 | 2 |
| 30 Jun 21 | 2 | -8 | 7 | 3 |
| 31 Mar 21 | 2 | -7 | 6 | 3 |
| 31 Dec 20 | 2 | -5 | 4 | 3 |
| 30 Sep 20 | 2 | -4 | 3 | 3 |
| 30 Jun 20 | 2 | -3 | 2 | 3 |
| 31 Mar 20 | 2 | -3 | 2 | 3 |
| 31 Dec 19 | 2 | -3 | 2 | 3 |
| 30 Sep 19 | 2 | -3 | 2 | 2 |
| 30 Jun 19 | 1 | -3 | 2 | 2 |
| 31 Mar 19 | 1 | -3 | 2 | 2 |
| 31 Dec 18 | 1 | -2 | 2 | 2 |
| 30 Sep 18 | 1 | -2 | 1 | 1 |
| 30 Jun 18 | 0 | -1 | 0 | 1 |
| 30 Apr 18 | 1 | 0 | 0 | 1 |
Quality Earnings: EMV is currently unprofitable.
Growing Profit Margin: EMV is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: EMV is unprofitable, but has reduced losses over the past 5 years at a rate of 0.7% per year.
Accelerating Growth: Unable to compare EMV's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: EMV is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-6.6%).
Return on Equity
High ROE: EMV has a negative Return on Equity (-14.74%), as it is currently unprofitable.